it does not suffice to implement a preventive strategy against nosocomial transmission based on the results Background. In dialysis patients, blood transfusions and long-term dialysis are well-known risk factors for of HCV antibody screening. Universal, rigorous implementation of adequate infection control measures transmission of hepatitis C virus ( HCV ). Transmission of HCV by transfusions has become extremely rare irrespective of HCV antibody status should be the cornerstone for prevention of nosocomial transmission since the introduction of antibody screening. However, nosocomial transmission of HCV within dialysis units of HCV and other blood borne pathogens. still occurs. We performed a survey of current infection Key words: HCV; haemodialysis; nosocomial; transmiscontrol measures against HCV in Dutch dialysis centres sion; infection prevention that had participated in a national HCV prevalence study.
guidelines describe cleaning and desinfection proced-haemodialysis patients, 93% of the centres performed routine follow-up screening for HCV antibodies at ures for instruments, equipment and surfaces. They also advise against sharing of items between patients, least once yearly (in 26% twice yearly and in 11% four times yearly). In chronic CAPD patients, 85% of the give specific instructions for hand washing and the use of gloves and other personal protective measures by centres performed follow-up screening once (48%) or twice (37%) yearly. In patients with unknown HCV health care workers.
In a recent national study in Dutch dialysis centres, status, only a minority of the centres took extra preventive measures against HCV ( Table 2) . Two of the prevalence of HCV infections among dialysis patients was determined with serological as well as these centres reserved the dialysis monitor for such a patient until the test result of HCV and hepatitis B molecular assays [15] . The purpose of the present study was to evaluate the infection control measures virus was available.
Twenty-four centres accepted guest patients for against HCV in those dialysis units where HCVpositive patients had been identified.
haemodialysis. Most of these centres dialysed less than 10 guest patients yearly. Ninety-two per cent of the centres requested HCV antibody screening for guest
Subjects and methods
patients in advance. However, in daily practice, 55% of the centres dialysed guest patients with an unknown HCV antibody status and some centres did not take Thirty-nine of 49 dialysis centres participated in a nationwide study on HCV prevalence in The Netherlands. All 27 centres any special precautions under these circumstances where HCV-infected patients had been identified (HCV ( Table 2) .
prevalence 1-8%) participated in the present study. A
In most centres routine infection control measures questionnaire was sent to each participating centre. After were more elaborate for HCV-positive patients than returning the questionnaire a structured interview with the for HCV-negative patients. New gloves were uniformly head nurse or their substitute was carried out by one of us applied for each individual patient. However, masks, (NT ). The questionnaire dealt with the following items: aprons and protective glasses were not universally used (i) screening procedures; (ii) screening and dialysis of guest ( Table 3) tion of the dialysis circuit. Surprisingly, 23 dialysis centres (85%) allowed their nurses to operate the dialysis monitor with their blood-contaminated gloves
Results
and only four of these centres required a routine change of gloves for handling different machines. Eight The characteristics of the participating centres are centres (30%) reported the incidental use of the same shown in Table 1 .
gloves for different patients in case of an emergency. In all but one centre, new dialysis patients were All centres disinfected the interior circuit of the screened for HCV antibodies ( Table 2 ). In chronic dialysis monitor at the end of each day. However, several centres did not apply this procedure between dialysis shifts, especially in serologically HCV-negative removed with both household and chemical detergents in 63% of the centres. There was no statistically significant relation between the applied disinfection or Only a few centres isolated their HCV-positive and at the end of the day in the participating centres (n=27) patients or dialysed them in a dedicated shift and/or on dedicated dialysis machines. The benefit of isolation measures on the HCV antibody status of their patients, In three centres HCV-positive patients were dialysed accurate identification of HCV-infected dialysis on a dedicated machine, and in two of them dialysis patients poses a serious problem. Sometimes HCV was performed in a separate room. In six centres HCV-antibody status of guest patients is not known. positive patients were treated on a dedicated shift. Moreover, compared to healthy controls, dialysis Bloodstains from HCV-positive patients were removed patients probably experience a more prolonged serowith alcohol in 6 units.
logical window phase after a recent HCV infection Reuse of artificial kidneys is not allowed in the [12, 17] . Thus, recent HCV infections can only be Netherlands.
accurately detected with HCV RNA assays. Only the combination of antibody assay and HCV RNA detection can accurately determine the prevalence and incid-
Discussion
ence of HCV-infection in dialysis patients [17, 18] . Therefore, in our opinion it is no longer justified to base the preventive strategy against HCV on the antiNosocomial transmission of HCV within dialysis units is increasingly recognized as a serious problem for body status of the patient.
Periodical screening for HCV in dialysis patients patients on renal replacement therapy [7] [8] [9] [10] [11] . Since the exact modes of transmission have not been elucid-should be used to monitor the epidemiology and the quality of the infection control measures against HCV ated, preventive measures should be aimed at the three speculative routes being, (i) hand-borne transmission within dialysis units. Both serology and molecular tools such as PCR should be used to detect viraemia through health-care workers, (ii) contamination through the dialysis monitor, and (iii) sharing of and analyse clusters of newly HCV-infected patients.
Genotyping and identification of related HCV strains equipment by patients [16 ] .
Our survey shows that the current policy for preven-by sequence analysis in a cluster of newly infected dialysis patients may enable us to point at nosocomial tion of HCV differs among Dutch dialysis centres and does not always meet the requirements of the Dutch transmission within a dialysis unit [11] .
Universal, rigorous implementation of adequate guidelines [13] .
In almost all centres, the routine infection control infection control measures irrespective of the HCV status remain the cornerstone for prevention of nosocmeasures for staff members and cleaning procedures of equipment depended more or less on the HCV omial transmission of HCV in dialysis units. In this way seroconversion rates can be kept low without antibody status of the patient. However, in daily routine practice, the majority of centres dialysed isolating HCV antibody positive patients [19] .
Moreover, such general precautions will contribute to (guest) patients with unknown HCV status without the usual precautions for HCV-positive patients. the prevention of other blood-borne pathogens. Centres implementing the use masks for HCV-negative patients had a higher prevalence of HCV infections.
